from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1772/-

LFCtreatmentdescriptionclass of inhibitor

-0.504

Amikacinug/mL Amikacintranslation

-0.656

Cap5-10ug/mL Capreomycintranslation

-0.078

Rox10-50 ug/mL Roxithromycintranslation

-0.565

SM2-5 ug/mL Streptomycintranslation

-0.834

Tet5-10 ug/mL Tetracyclinetranslation

0.601

Rif0.2-5ug/mL Rifampicintranscription

0.345

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.126

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.959

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.120

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.196

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.606

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.658

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.131

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.057

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.695

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.000

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.665

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.769

Nigericin50 uM Nigericinrespiration

0.333

TRC10-150 ug/mL Triclosanrespiration

0.021

TRZ10-25 ug/mL Thioridazinerespiration

-0.081

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.625

menadione6-10 ug/mL Menadionerespiration

-1.866

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.663

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.730

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.381

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.029

NRP_1Non-replicating persistence stage 1dosRassociated

0.397

Amp0.2mg/mL AmpicillincellWall

0.719

Cephalexin20-100 ug/mL CephalexincellWall

0.899

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.038

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.643

EMB10-20 ug/mL EthambutolcellWall

1.083

Eta12-40 ug/mL EthionamidecellWall

1.225

INH0.2-0.4 ug/mL IsoniazidcellWall

1.156

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.644

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.383

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.226

BZA0.12 mg/mL BenzamidearomaticAmides

-0.459

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.575

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.510

H2O24 mM hydrogen peroxideDNAdamaging

-0.217

Levo10 ug/mL LevofloxacinDNAdamaging

-0.668

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.905

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.526

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.021

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.682

Antimycin12.5-50 ug/mL Antimycin A?

0.071

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.135

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.075

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.143

PA8240.2-2 ug/mL PA-824?

0.632

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.011

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.309

Verapamil50 uM Verapamil?

-1.228

mercaptoethanol2 mM 2-Mercaptoethanol?

1.927

methoxatin10-20 ug/mL Methoxatin?